Market Tracker

05/22 3:27pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

34.15
BATS BZX Real-Time Price
As of 3:26pm ET
 +0.45 / +1.34%
Today’s Change
17.25
Today|||52-Week Range
34.25
+35.25%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close33.70
Today’s open33.85
Day’s range33.85 - 34.25
Volume17,984
Average volume (3 months)553,270
Market cap$1.7B
Dividend yield--
Data as of 3:26pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-37.05%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio18.3
Price/Sales6.07
Price/Book8.78

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.40+0.77%
HZNPHorizon Pharma PLC-0.20-1.86%
LXRXLexicon Pharmaceutic...-0.07-0.48%
PCRXPacira Pharmaceutica...-1.20-2.48%
Data as of 3:27pm ET, 05/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts